首页> 外文OA文献 >Potential role of vitamin D in restoring sensitivity to mTOR inhibitors in hepatocellular carcinoma (HCC): 1,25(OH)vitamin D (VITD) reverts everolimus (EVE) resistance in a HCC cell line

【2h】

Potential role of vitamin D in restoring sensitivity to mTOR inhibitors in hepatocellular carcinoma (HCC): 1,25(OH)vitamin D (VITD) reverts everolimus (EVE) resistance in a HCC cell line

机译：维生素D在肝细胞癌（HCC）中对MTOR抑制剂敏感性的潜在作用：1,25（OH）维生素D（VITD）在HCC细胞系中恢复威洛米斯（EVE）抗性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Claudia Pivonello; Donatella Paola Provvisiero; Mariarosaria Negri; Gennaro Gilda Di; Angelis Cristina De; Giacomo Galdiero; Chiara Simeoli; Martino Maria Cristina De; Annamaria Colao; Rosario Pivonello;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375/oncogenes circuit [J] . Donatella Paola Provvisiero, Mariarosaria Negri, Cristina de Angelis, Scientific reports. . 2019,第1期

机译：维生素D通过激活miR-375 / oncogenes回路来恢复对肝细胞癌中的MTOR抑制剂血管毒蕈的抗性
2. Demographic and Clinical Outcomes of Patients with Hepatocellular Carcinoma(HCC) NOS compared with Clear Cell Hepatocellular Carcinoma(HCC): A United States Population Based Analysis (SEER 1973-2013) [J] . Kaushik Manu, Patil Sachin, Jacobs Michael Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：与透明细胞肝细胞癌（HCC）相比，肝细胞癌（HCC）NoS的人口和临床结果：基于美国的人口分析（SEER 1973-2013）
3. C6 ceramide sensitizes the anti-hepatocellular carcinoma (HCC) activity by AZD-8055, a novel mTORC1/2 dual inhibitor [J] . Liu Mo, Gu Peng, Guo Wenjia, Tumour biology : . 2016,第8期

机译：C6神经酰胺通过新型mTORC1 / 2双重抑制剂AZD-8055增强抗肝癌（HCC）活性。
4. The changing but continued role of surgery in the management of liver tumours Hepatoblastoma (HB) and Hepatocellular Carcinoma (HCC) in children and adolescents in the -light of new results from the SIOPEL Studies- past experience and future perspectives [C] . . 2006

机译：根据SIOPEL研究的新结果-过去的经验和未来的观点，外科手术在儿童和青少年肝肿瘤肝母细胞瘤（HB）和肝细胞癌（HCC）处理中的作用不断变化，但仍在继续
5. Sesquiterpene drugs as potential treatment for hepatocellular carcinoma (HCC): Preclinical evaluation of parthenolide administered via transarterial chemoembolization in a rat HCC tumor model. [D] . Chen, Zheng. 2016

机译：倍半萜类药物可作为肝细胞癌（HCC）的潜在治疗方法：在大鼠HCC肿瘤模型中，通过经动脉化学栓塞术施用的小白菊内酯的临床前评估。
6. Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375/oncogenes circuit [O] . Donatella Paola Provvisiero, Mariarosaria Negri, Cristina de Angelis, -1

机译：维生素D通过激活miR-375 /癌基因回路恢复肝细胞癌中对mTOR抑制剂依维莫司的耐药性
7. Co-Medication and nutrition in HCC: Potentially preventative strategies in Hepatocellular carcinoma (HCC) [O] . Alexander Kusnik, Nicole Hunter, Erik Rasbach, 2021

机译：HCC中的共同用药和营养：肝细胞癌（HCC）中的潜在预防策略

Potential role of vitamin D in restoring sensitivity to mTOR inhibitors in hepatocellular carcinoma (HCC): 1,25(OH)vitamin D (VITD) reverts everolimus (EVE) resistance in a HCC cell line

著录项

引文网络

相似文献

相关主题

期刊订阅